NKCFO LLC’s Tandem Diabetes Care TNDM Stock Holding History

NKCFO LLC’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-655	Closed	-$76K	–	127
2022 Q1	$76K	Hold	655	–	–	0.02%	100
2021 Q4	$99K	Buy	+655	New	+$88.4K	0.03%	86

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

NKCFO LLC's TNDM Position: Q2 2022 in Review

NKCFO LLC sold out of Tandem Diabetes Care (TNDM) in Q2 2022, closing a stake of 655 shares — an estimated $76K sold.

NKCFO LLC first reported a position in TNDM in Q4 2021 and held it in 2 quarters. The position peaked at $99K in Q4 2021. 330 funds tracked by Wall St. Rank hold TNDM as of Q2 2022.

NKCFO LLC reported no remaining Tandem Diabetes Care position as of Q2 2022 after selling out during the quarter.
NKCFO LLC sold 655 Tandem Diabetes Care shares in Q2 2022, an estimated $76K.
NKCFO LLC first reported a position in Tandem Diabetes Care in Q4 2021 and held it in 2 quarters.
NKCFO LLC's Tandem Diabetes Care position peaked at $99K in Q4 2021.
330 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2022.

Based on NKCFO LLC's 13F filing for Q2 2022, filed 8 Jul 2022.